Development and Application of Novel Glycan-Specific Reagents to Facilitate Early
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early
批准号:
8072313
负责人:
DANIEL L COMINS
金额:
$33.05万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2014-08-31
关键词:
AddressAgeAge-MonthsAnimal ModelAnimalsBiologicalBiological MarkersBirdsBloodCA-125 AntigenChargeChemicalsChemistryChickensCleaved cellCollectionCommunitiesComplex MixturesDataDetectionDevelopmentDiagnosisDiagnosticDiseaseDissociationERBB2 geneEarly DiagnosisElectrospray IonizationEpithelial ovarian cancerEvaluationFoundationsFrequenciesGoalsHealthHeart DiseasesHomeostasisHumanImmune System DiseasesIndividualIonsLaboratory StudyLibrariesLinkMalignant NeoplasmsMass Spectrum AnalysisMeasurementMeasuresMethodsModelingMolecularMolecular WeightPathologyPlasmaPlasma ProteinsPlayPolysaccharidesPopulationPost-Translational RegulationPrevalenceProtein GlycosylationReagentReference ValuesRegulationRelative (related person)ResearchRoleSamplingScienceSolidStable Isotope LabelingStagingStructureSurvival RateSystems BiologyTechniquesTechnologyTestingTissuesTranslatingUp-RegulationUpdateWomananalytical toolanticancer researchbasebiobankcohortcomparativedesignimprovedinsightinstrumentationionization techniquemass analyzerneurodevelopmentnovelopen sourceprognosticresponsestable isotopetime intervaltooluser-friendlyweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mass spectrometry is an extraordinarily powerful bio-analytical technique that has had a profound impact on our molecular understanding of human health and disease. Major advances in mass analyzer technology, dissociation techniques, and ionization methods are largely attributed to the central role that mass spectrometry plays in the field of systems biology. While mass spectrometry has evolved over the last century into a highly effective analytical tool, there are still opportunities for new advances to be made allowing an even more diverse array of biological questions to be addressed. This proposal is centered on the development and characterization of novel glycan- specific tags for biological mass spectrometry that facilitate the relative quantification of glycans cleaved from plasma proteins with increased ion abundance. The short-term objective of this proposal is to develop these novel tags and then test them using the avian model of spontaneous epithelial ovarian cancer. These results will provide a solid bio-analytical technology foundation from which our newly developed chemical tags can be applied to achieve the long-term objective of effectively elucidating glycan biomarkers for the early detection of epithelial ovarian cancer in women. Public Description of Proposed Research Mass spectrometry (MS), the science related to the "weighing of molecules", has had a profound impact on the study of human health and disease including cancer, heart disease, neural development, and auto-immune diseases. However, front-end chemistries for MS-based glycomics will be exploited to dramatically improve the ability of MS to detect and quantify glycans cleaved from plasma proteins. This will allow a more diverse array of contemporary biomedical questions to be addressed including the quantification of diagnostic and prognostic biomarkers. This proposal is squarely centered on the elucidation of a glycan-specific biomarker(s) for the early detection of epithelial ovarian cancer.
PUBLIC HEALTH RELEVANCE: This proposal seeks support to develop and apply novel tags that will facilitate both global and targeted quantitative mass spectrometric analysis of N-linked glycans with significantly improved limits-of-detection. Once synthesized, the novel tags and ancillary methods will concurrently be applied to the experimental chicken model of spontaneous epithelial ovarian cancer for comparative analysis (i.e., biomarker discovery) and fully disseminated to the glycomics research community. The long-term application of these novel tags, as developed in our laboratory for this study, will be their use to elucidate glycan biomarkers for the early detection of epithelial ovarian cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early
-
批准号:8494122
-
项目类别:
-
资助金额:$5.54万
-
财政年份:2012
-
负责人:DANIEL L COMINS
-
依托单位:
Development and Application of Novel Glycan-Specific Reagents to Facilitate Early
-
批准号:8327164
-
项目类别:
-
资助金额:$35.38万
-
财政年份:2011
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6130508
-
项目类别:
-
资助金额:$27.69万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:3285446
-
项目类别:
-
资助金额:$5.31万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285439
-
项目类别:
-
资助金额:$5.38万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6338151
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285444
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6701194
-
项目类别:
-
资助金额:$1.32万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:2391967
-
项目类别:
-
资助金额:$25.51万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:2684789
-
项目类别:
-
资助金额:$25.1万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
ALKALOID SYNTHESIS VIA 2-ALKENYL-1,2-DIHYDROPYRIDINES
-
批准号:3277914
-
项目类别:
-
资助金额:$7.24万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285443
-
项目类别:
-
资助金额:$8.79万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:2177424
-
项目类别:
-
资助金额:$25.25万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6924410
-
项目类别:
-
资助金额:$9.65万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
ALKALOID SYNTHESIS VIA 2-ALKENYL-1,2-DIHYDROPYRIDINES
-
批准号:3277913
-
项目类别:
-
资助金额:$7.4万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285445
-
项目类别:
-
资助金额:$21.03万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6385559
-
项目类别:
-
资助金额:$28.64万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285437
-
项目类别:
-
资助金额:$15.22万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS AND SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINE
-
批准号:6519165
-
项目类别:
-
资助金额:$26.36万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINES
-
批准号:3285438
-
项目类别:
-
资助金额:$2.75万
-
财政年份:1989
-
负责人:DANIEL L COMINS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: